CRISPR/Cas9 Platform has successfully implied CRISPR-mediated gene transcriptional inhibition in a variety of cells, which facilitates further research on gene transcriptional regulation mechanisms, gene functions, and screening of drug targets. Based on our platform, we are able to offer you custom CRISPRi stable cell line services, from strategic design to stable cells. We guarantee three homozygous (or heterozygous) clones in which the modified line has the correct genetic mutation and three vials of each clone.
